BioCryst Pharmaceuticals.

PositionTRIANGLE BRIEFS: DURHAM

BioCryst Pharmaceuticals, which develops drugs for rare diseases, plans to merge with Exton, Pa.-based Idera Pharmaceuticals. Vincent Milano, CEO of Idera, will lead the new company, which will be based in Exton. BioCryst Chairman Robert Ingram will...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT